Duration of prophylaxis with trimethoprim–sulfamethoxazole in patients undergoing solid organ transplantation

[1] Fishman JA(2007)Infection in solid-organ transplant recipients N Engl J Med 357 2601-2614

[2] Fishman JA(2001)Prevention of infection caused by Clin Infect Dis 33 1397-1405

[3] Martin SI(2009) in transplant recipients Am J Transplant 9 S227-S233

[4] Fishman JA(1994)Pneumocystis pneumonia in solid organ transplant recipients J Infect 29 249-253

[5] Orr KE(2009)Outcome of Transplantation 88 135-141

[6] Gould FK(2009) mismatches in heart transplant recipients over a period of 8 years Transplant Proc 41 1201-1203

[7] Short G(1990)Analysis of USRDS: incidence and risk factors for Am J Med 89 255-274

[8] Neff RT(2009) pneumonia Transplantation 88 380-385

[9] Jindal RM(1996)A systematic review of two different trimetoprim–sulfamethoxazole regimens used to prevent Clin Infect Dis 22 920-925

[10] Yoo DY(2010) and no prophylaxis at all in transplant recipients: appraising the evidence Clin Microbiol Infect 16 1375-1377

[1] Fishman JA(2007)Infection in solid-organ transplant recipients N Engl J Med 357 2601-2614

[2] Fishman JA(2001)Prevention of infection caused by Clin Infect Dis 33 1397-1405

[3] Martin SI(2009) in transplant recipients Am J Transplant 9 S227-S233

[4] Fishman JA(1994)Pneumocystis pneumonia in solid organ transplant recipients J Infect 29 249-253

[5] Orr KE(2009)Outcome of Transplantation 88 135-141

[6] Gould FK(2009) mismatches in heart transplant recipients over a period of 8 years Transplant Proc 41 1201-1203

[7] Short G(1990)Analysis of USRDS: incidence and risk factors for Am J Med 89 255-274

[8] Neff RT(2009) pneumonia Transplantation 88 380-385

[9] Jindal RM(1996)A systematic review of two different trimetoprim–sulfamethoxazole regimens used to prevent Clin Infect Dis 22 920-925

[10] Yoo DY(2010) and no prophylaxis at all in transplant recipients: appraising the evidence Clin Microbiol Infect 16 1375-1377